慢性肺炎的低诊断:日本COPD真实世界数据流行病学 (CORE) 研究
Yuka Koga1, Sayaka Deguchi1, Takeshi Matsuo1
1Pharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.
概括
这项研究发现,只有4.0%的日本成年人患有气流阻塞,其中很少有人被诊断为慢性阻塞性肺病 (COPD). 提高认识和早期检测对于改善COPD诊断率至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 空气流阻塞影响了日本人口的很大一部分,之前的估计在3.8%至16.9%之间.
- 慢性阻塞性肺病 (COPD) 是一个主要的公共卫生问题,往往被诊断不足.
研究的目的:
- 用大型数据库重新评估日本空气流阻塞的流行情况.
- 为了确定COPD的诊断率在患有气流阻塞的个体中.
主要方法:
- 来自JMDC的医疗保险索赔和健康检查数据的分析.
- 包括40岁及以上的个人,他们在2019年接受了螺旋计.
- 评估气流阻塞的患病率,COPD诊断率,疾病阶段和呼吸功能.
主要成果:
- 在102,190名参与者中,4.0%的人 (5.3%的男性,2.1%的女性) 患有气流阻塞.
- 只有8.4%的空气流阻塞患者接受了COPD诊断.
- 被诊断为COPD的患者的FEV1/FVC和FEV1值明显较低,表明疾病更为晚期.
结论:
- 在日本,患有空气流阻塞的患者中,COPD诊断率特别低.
- 迫切需要提高公众和医生对COPD的认识.
- 在初级保健医生和肺病学家之间加强合作对于早期发现COPD和改善诊断率至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Pathogenesis and Clinical Features
263
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
263
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Bias in Epidemiological Studies
251
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
251
COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


